The modified Atkins diet.
Level 5 - mechanism / opinion, no new human data
Narrative review summarizing eight non-randomized prospective and retrospective studies.
PubMed 19049584 · doi:10.1111/j.1528-1167.2008.01831.x
What was done
The author reviewed the implementation, side effect profile, and efficacy of the Modified Atkins Diet (MAD)—a high-fat regimen restricting carbohydrates to 10 g/day in children and 15 g/day in adults without fluid, calorie, or protein restrictions, initiated on an outpatient basis without fasting. The review synthesizes findings from eight published prospective and retrospective studies in children and adults with epilepsy.
What was found
Across the eight reported studies (evaluating approximately 100 patients): - 45 patients (45%) achieved a 50% to 90% seizure reduction. - 28 patients (28%) achieved greater than 90% seizure reduction. The author noted these response rates are comparable to outcomes seen with the traditional ketogenic diet.
Why it matters
The modified Atkins diet provides a less restrictive, outpatient-initiated dietary therapy alternative to the classic ketogenic diet for epilepsy management, requiring no fasting or caloric restriction while yielding notable seizure reduction rates in observational studies.
Limits
The supporting data stem from uncontrolled prospective and retrospective case cohorts rather than randomized controlled trials. The abstract lacks specific data on long-term adherence, comparative control groups, precise total patient counts, adverse events, or statistical confidence intervals.
Cited by
- supports Published work by Eric Kossoff shows that the modified Atkins diet has comparable therapeutic potency to the strict classical 4:1 ketogenic diet.